REASONS TO SUPPORT GARDP NORTH AMERICA
Millions of people in North America and worldwide contract infections from harmful bacteria and are increasingly dying due to the lack of effective antibiotics. Your donation will support the research and development of urgently needed antibiotics, and availability of these treatments, for all who need them.
Health is a powerful driver of productivity, social stability, and economic growth. Everyone’s health is dependent on effective antibiotics. Investing in the research and development of new treatments is good value for money that helps build a more prosperous future.
Drug-resistant bacterial infections can infect anyone, of any age, in any country. But it is our most vulnerable who are hit first and hardest. You can support the research and development of antibiotics to protect those most at risk: newborns, people with weakened immune systems, those in hospitals requiring medical procedures, and older adults.
TAKE ACTION NOW. DONATE TO SUPPORT OUR WORK.
PARTNER WITH US
We need partners at every step of the research and development process and to deliver these lifesaving and lifechanging treatments.
Your support will allow us to develop antibacterial compounds, perform clinical trials, and carry out research on the best use of treatments. It will fund critical work to make available antibiotics for every person who needs them and to ensure treatments remain effective for as long as possible.
INVEST IN HEALTH
Your support for GARDP North America goes toward antibiotic research and development that helps safeguard modern healthcare. We work with diverse funders—including governments, foundations and philanthropists—who are committed to developing treatments to improve health and save lives.
EXPERTISE AND INNOVATION
We partner with diverse companies and sectors to tackle the complex challenges in antibiotic research, development, and access. For example, in North America, we’re working with Entasis Therapeutics on the development of a new treatment active against resistant strains of gonorrhea and with Venatorx Pharmaceuticals on an antibiotic treatment for hard-to-treat hospital infections.
We also champion scientific knowledge-sharing at a global level. To that end, we’ve developed REVIVE, a comprehensive global online platform on antimicrobial drug research. On the REVIVE website, we invite the antimicrobial R&D community to connect, share, and find information.
ADVOCACY AND AWARENESS
We are raising awareness in the U.S. and globally of the urgent need to develop new antibiotics. Our partners help spread the word about our work and impact, and they also call for action and essential funding to address the health crisis of drug-resistant infections.
STAY INFORMED AND CONNECTED
The response to antibiotic resistance is rapidly changing. Stay informed about new developments in the field of antibiotic resistance and our efforts to deliver new treatments for drug-resistant infections.
SPREAD THE WORD
Help us tell people about the threat of antibiotic resistance and what GARDP is doing to address it. Find a story on GARDP’s global website, Twitter, LinkedIn or YouTube and share it with your networks.